Medicine and Dentistry
Bevacizumab
100%
Eye Inflammation
100%
Lipopolysaccharide
57%
Peptidoglycan
57%
Vasculotropin
42%
Chemokine
42%
Antibiotics
28%
Tumor Necrosis Factor
28%
Endophthalmitis
28%
Cytokine
28%
Iris
28%
Interleukin-6
28%
Interleukin-1
28%
Vitrectomy
28%
RANTES
28%
Irritant Agent
28%
Microvessel
14%
Adjuvant Therapy
14%
Granulocyte Colony Stimulating Factor
14%
Anti-Inflammatory Drug
14%
Leukocyte
14%
Interleukin 17
14%
Serositis
14%
Visual Impairment
14%
Enucleation
14%
Inflammatory Cytokine
14%
Granulocyte Macrophage Colony Stimulating Factor
14%
Eotaxin
14%
Eye Surgery
14%
Intravital Microscopy
14%
Leukocyte Adherence
14%
Antiinflammatory Activity
14%
Antiinflammatory Agent
14%
Interleukin 13
14%
Immunoglobulin G1 Antibody
14%
Vascular Endothelium
14%
Keyphrases
Intravitreal Bevacizumab
100%
Intravitreal Antibiotics
50%
Bevacizumab Treatment
25%
Pharmacology, Toxicology and Pharmaceutical Science